| scholarly article | Q13442814 |
| P2093 | author name string | Andrea Carter | |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phase III clinical trial | Q42824827 |
| P304 | page(s) | 675-677 | |
| P577 | publication date | 2010-05-11 | |
| P1433 | published in | Journal of the National Cancer Institute | Q400279 |
| P1476 | title | Integrins as target: first phase III trial launches, but questions remain | |
| P478 | volume | 102 |
| Q35216941 | Beta1 integrin cytoplasmic tyrosines promote skin tumorigenesis independent of their phosphorylation |
| Q38728877 | Brain invasion in Meningiomas - Clinical considerations and impact of neuropathological evaluation: A systematic Review |
| Q35078406 | Cilengitide-induced temporal variations in transvascular transfer parameters of tumor vasculature in a rat glioma model: identifying potential MRI biomarkers of acute effects |
| Q64926507 | Current state of in vivo panning technologies: Designing specificity and affinity into the future of drug targeting. |
| Q30524330 | Dynamic PET and Optical Imaging and Compartment Modeling using a Dual-labeled Cyclic RGD Peptide Probe |
| Q37057299 | ITGAV and ITGA5 diversely regulate proliferation and adipogenic differentiation of human adipose derived stem cells. |
| Q36230578 | Immunohistochemical analysis of integrins αvβ3, αvβ5 and α5β1, and their ligands, fibrinogen, fibronectin, osteopontin and vitronectin, in frozen sections of human oral head and neck squamous cell carcinomas |
| Q33709432 | Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair |
| Q43501092 | Integrins and their ligands are expressed in non-small cell lung cancer but not correlated with parameters of disease progression |
| Q37795552 | Integrins as therapeutic targets: lessons and opportunities |
| Q36065429 | Integrins αvβ3 and αvβ5 as prognostic, diagnostic, and therapeutic targets in gastric cancer |
| Q93007229 | Modulating Tumor Cell Functions by Tunable Nanopatterned Ligand Presentation |
| Q36111439 | Novel synthetic cyclic integrin αvβ3 binding peptide ALOS4: Antitumor activity in mouse melanoma models. |
| Q35864258 | Pharmacological Inhibition of β3 Integrin Reduces the Inflammatory Toxicities Caused by Oncolytic Adenovirus without Compromising Anticancer Activity. |
| Q42673758 | Proteome-wide analysis of human disease mutations in short linear motifs: neglected players in cancer? |
| Q92076388 | Targeting the complexity of Src signalling in the tumour microenvironment of pancreatic cancer: from mechanism to therapy |
| Q57691813 | The development of a highly photostable and chemically stable zwitterionic near-infrared dye for imaging applications |
| Q37851151 | Therapeutic targeting of tumor-stroma interactions. |
| Q27015980 | Tumor stroma as targets for cancer therapy |
Search more.